Limits of the Current Evidence Most BPC-157 research remains preclinical
This leads to unnecessary dose escalations, switching to different medications, or abandoning treatment altogether, all because the syringe draw was off by 10 to 20 percent
A 2021 In another recent meta-analysis, researchers found that individuals with ulcerative colitis (UC) who took curcumin and mesalamine, a drug used to treat UC, were almost three times more likely to achieve remission than those who took mesalamine alone
Researchers value its sterile composition, multi-use design, and easy handling for controlled investigational procedures
Your doctor will check how youre doing during this time
Figure 5: Change in Body Weight (%) After 12-Week Intensive Lifestyle Intervention Lead-In Followed by Randomized Treatment and a Standard Lifestyle Intervention (Study 3) in Patients with Obesity or Overweight Note: Displayed results are from the randomized Population